NADPH oxidase and PKC contribute to increased na transport by the thick ascending limb during type 1 diabetes

Jing Yang, Jennifer S. Pollock, Pamela K Carmines

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Type 1 diabetes triggers protein kinase C (PKC)-dependent NADPH oxidase activation in the renal medullary thick ascending limb (mTAL), resulting in accelerated superoxide production. As acute exposure to superoxide stimulates NaCl transport by the mTAL, we hypothesized that diabetes increases mTAL Na + transport through PKC-dependent and NADPH oxidase-dependent mechanisms. An O 2-sensitive fluoroprobe was used to measure O 2 consumption by mTALs from rats with streptozotocin-induced diabetes and sham rats. In sham mTALs, total O 2 consumption was evident as a 0.34±0.03 U change in normalized relative fluorescence (ΔNRF)/min per mg protein. Ouabain (2 mmol/L) reduced O 2 consumption by 69±4% and 500 μmol/L furosemide reduced O 2 consumption by 58±8%. Total O 2 consumption was accelerated in mTAL from diabetic rats (0.74±0.07 ΔNRF/min/mg protein; P<0.05 versus sham), reflecting increases in ouabain- and furosemide-sensitive O 2 consumption. NADPH oxidase inhibition (100 μmol/L apocynin) reduced furosemide-sensitive O 2 consumption by mTAL from diabetic rats to values not different from sham. The PKC inhibitor calphostin C (1 μmol/L) or the PKCα/β inhibitor Gö6976 (1 μmol/L) decreased furosemide-sensitive O 2 consumption in both groups, achieving values that did not differ between sham and diabetic. PKCβ inhibition had no effect in either group. Similar inhibitory patterns were evident with regard to ouabain-sensitive O 2 consumption. We conclude that NADPH oxidase and PKC (primarily PKCα) contribute to an increase in O 2 consumption by the mTAL during type 1 diabetes through effects on the ouabain-sensitive Na +-K +-ATPase and furosemide-sensitive Na +-K +-2Cl - cotransporter that are primarily responsible for active transport Na + reabsorption by this nephron segment.

Original languageEnglish (US)
Pages (from-to)431-436
Number of pages6
JournalHypertension
Volume59
Issue number2 SUPPL. 1
DOIs
StatePublished - Feb 1 2012

Fingerprint

NADPH Oxidase
Type 1 Diabetes Mellitus
Protein Kinase C
Furosemide
Extremities
Ouabain
Protein C Inhibitor
Protein Kinase Inhibitors
Superoxides
Fluorescence
Experimental Diabetes Mellitus
Active Biological Transport
Nephrons
Carrier Proteins
Proteins
Kidney

Keywords

  • NADPH oxidase
  • oxygen consumption
  • protein kinase C
  • sodium reabsorption
  • thick ascending limb
  • type 1 diabetes

ASJC Scopus subject areas

  • Internal Medicine

Cite this

NADPH oxidase and PKC contribute to increased na transport by the thick ascending limb during type 1 diabetes. / Yang, Jing; Pollock, Jennifer S.; Carmines, Pamela K.

In: Hypertension, Vol. 59, No. 2 SUPPL. 1, 01.02.2012, p. 431-436.

Research output: Contribution to journalArticle

@article{1d0e66fc258d4960b6590bcda1556e81,
title = "NADPH oxidase and PKC contribute to increased na transport by the thick ascending limb during type 1 diabetes",
abstract = "Type 1 diabetes triggers protein kinase C (PKC)-dependent NADPH oxidase activation in the renal medullary thick ascending limb (mTAL), resulting in accelerated superoxide production. As acute exposure to superoxide stimulates NaCl transport by the mTAL, we hypothesized that diabetes increases mTAL Na + transport through PKC-dependent and NADPH oxidase-dependent mechanisms. An O 2-sensitive fluoroprobe was used to measure O 2 consumption by mTALs from rats with streptozotocin-induced diabetes and sham rats. In sham mTALs, total O 2 consumption was evident as a 0.34±0.03 U change in normalized relative fluorescence (ΔNRF)/min per mg protein. Ouabain (2 mmol/L) reduced O 2 consumption by 69±4{\%} and 500 μmol/L furosemide reduced O 2 consumption by 58±8{\%}. Total O 2 consumption was accelerated in mTAL from diabetic rats (0.74±0.07 ΔNRF/min/mg protein; P<0.05 versus sham), reflecting increases in ouabain- and furosemide-sensitive O 2 consumption. NADPH oxidase inhibition (100 μmol/L apocynin) reduced furosemide-sensitive O 2 consumption by mTAL from diabetic rats to values not different from sham. The PKC inhibitor calphostin C (1 μmol/L) or the PKCα/β inhibitor G{\"o}6976 (1 μmol/L) decreased furosemide-sensitive O 2 consumption in both groups, achieving values that did not differ between sham and diabetic. PKCβ inhibition had no effect in either group. Similar inhibitory patterns were evident with regard to ouabain-sensitive O 2 consumption. We conclude that NADPH oxidase and PKC (primarily PKCα) contribute to an increase in O 2 consumption by the mTAL during type 1 diabetes through effects on the ouabain-sensitive Na +-K +-ATPase and furosemide-sensitive Na +-K +-2Cl - cotransporter that are primarily responsible for active transport Na + reabsorption by this nephron segment.",
keywords = "NADPH oxidase, oxygen consumption, protein kinase C, sodium reabsorption, thick ascending limb, type 1 diabetes",
author = "Jing Yang and Pollock, {Jennifer S.} and Carmines, {Pamela K}",
year = "2012",
month = "2",
day = "1",
doi = "10.1161/HYPERTENSIONAHA.111.184796",
language = "English (US)",
volume = "59",
pages = "431--436",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "2 SUPPL. 1",

}

TY - JOUR

T1 - NADPH oxidase and PKC contribute to increased na transport by the thick ascending limb during type 1 diabetes

AU - Yang, Jing

AU - Pollock, Jennifer S.

AU - Carmines, Pamela K

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Type 1 diabetes triggers protein kinase C (PKC)-dependent NADPH oxidase activation in the renal medullary thick ascending limb (mTAL), resulting in accelerated superoxide production. As acute exposure to superoxide stimulates NaCl transport by the mTAL, we hypothesized that diabetes increases mTAL Na + transport through PKC-dependent and NADPH oxidase-dependent mechanisms. An O 2-sensitive fluoroprobe was used to measure O 2 consumption by mTALs from rats with streptozotocin-induced diabetes and sham rats. In sham mTALs, total O 2 consumption was evident as a 0.34±0.03 U change in normalized relative fluorescence (ΔNRF)/min per mg protein. Ouabain (2 mmol/L) reduced O 2 consumption by 69±4% and 500 μmol/L furosemide reduced O 2 consumption by 58±8%. Total O 2 consumption was accelerated in mTAL from diabetic rats (0.74±0.07 ΔNRF/min/mg protein; P<0.05 versus sham), reflecting increases in ouabain- and furosemide-sensitive O 2 consumption. NADPH oxidase inhibition (100 μmol/L apocynin) reduced furosemide-sensitive O 2 consumption by mTAL from diabetic rats to values not different from sham. The PKC inhibitor calphostin C (1 μmol/L) or the PKCα/β inhibitor Gö6976 (1 μmol/L) decreased furosemide-sensitive O 2 consumption in both groups, achieving values that did not differ between sham and diabetic. PKCβ inhibition had no effect in either group. Similar inhibitory patterns were evident with regard to ouabain-sensitive O 2 consumption. We conclude that NADPH oxidase and PKC (primarily PKCα) contribute to an increase in O 2 consumption by the mTAL during type 1 diabetes through effects on the ouabain-sensitive Na +-K +-ATPase and furosemide-sensitive Na +-K +-2Cl - cotransporter that are primarily responsible for active transport Na + reabsorption by this nephron segment.

AB - Type 1 diabetes triggers protein kinase C (PKC)-dependent NADPH oxidase activation in the renal medullary thick ascending limb (mTAL), resulting in accelerated superoxide production. As acute exposure to superoxide stimulates NaCl transport by the mTAL, we hypothesized that diabetes increases mTAL Na + transport through PKC-dependent and NADPH oxidase-dependent mechanisms. An O 2-sensitive fluoroprobe was used to measure O 2 consumption by mTALs from rats with streptozotocin-induced diabetes and sham rats. In sham mTALs, total O 2 consumption was evident as a 0.34±0.03 U change in normalized relative fluorescence (ΔNRF)/min per mg protein. Ouabain (2 mmol/L) reduced O 2 consumption by 69±4% and 500 μmol/L furosemide reduced O 2 consumption by 58±8%. Total O 2 consumption was accelerated in mTAL from diabetic rats (0.74±0.07 ΔNRF/min/mg protein; P<0.05 versus sham), reflecting increases in ouabain- and furosemide-sensitive O 2 consumption. NADPH oxidase inhibition (100 μmol/L apocynin) reduced furosemide-sensitive O 2 consumption by mTAL from diabetic rats to values not different from sham. The PKC inhibitor calphostin C (1 μmol/L) or the PKCα/β inhibitor Gö6976 (1 μmol/L) decreased furosemide-sensitive O 2 consumption in both groups, achieving values that did not differ between sham and diabetic. PKCβ inhibition had no effect in either group. Similar inhibitory patterns were evident with regard to ouabain-sensitive O 2 consumption. We conclude that NADPH oxidase and PKC (primarily PKCα) contribute to an increase in O 2 consumption by the mTAL during type 1 diabetes through effects on the ouabain-sensitive Na +-K +-ATPase and furosemide-sensitive Na +-K +-2Cl - cotransporter that are primarily responsible for active transport Na + reabsorption by this nephron segment.

KW - NADPH oxidase

KW - oxygen consumption

KW - protein kinase C

KW - sodium reabsorption

KW - thick ascending limb

KW - type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84856118706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856118706&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.111.184796

DO - 10.1161/HYPERTENSIONAHA.111.184796

M3 - Article

VL - 59

SP - 431

EP - 436

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 2 SUPPL. 1

ER -